Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel

NACompletedINTERVENTIONAL

Enrollment

2,472

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

February 11, 2022

Study Completion Date

February 11, 2022

Conditions

COVID-19Influenza AInfluenza Type B

Interventions

DEVICE

COVID-19/ Flu A&B Rapid Panel

Rapid Diagnostic Device

Trial Locations (1)

Urgent Care, Easley

All Listed Sponsors

lead

Abbott Rapid Diagnostics Jena GmbH

INDUSTRY

NCT05163730 - Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel | Biotech Hunter | Biotech Hunter